Literature DB >> 35441909

Response to Letter to the Editor 'Serum irisin concentration in patients with bladder cancer'.

Kerem Taken1, Rahmi Aslan1, Recep Eryilmaz1, Hamit Hakan Alp2, Zübeyir Huyut2, Muhammet İrfan Dönmez3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35441909     DOI： 10.1007/s11255-022-03215-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  5 in total

1.  The diagnostic and prognostic roles of serum irisin in bladder cancer.

Authors:  Marwa M Esawy; Khalid M Abdel-Samd
Journal:  Curr Probl Cancer       Date:  2019-11-20       Impact factor: 3.187

2.  Serum irisin concentration in patients with bladder cancer.

Authors:  Tomoyuki Kawada
Journal:  Int Urol Nephrol       Date:  2022-04-01       Impact factor: 2.370

3.  Serum irisin is a novel biomarker for bladder cancer detection.

Authors:  Kerem Taken; Rahmi Aslan; Recep Eryilmaz; Hamit Hakan Alp; Zübeyir Huyut; Muhammet İrfan Dönmez
Journal:  Int Urol Nephrol       Date:  2021-11-22       Impact factor: 2.370

4.  Comparison of commercial ELISA assays for quantification of corticosterone in serum.

Authors:  Anne Marie Kinn Rød; Nina Harkestad; Finn Konow Jellestad; Robert Murison
Journal:  Sci Rep       Date:  2017-07-27       Impact factor: 4.379

Review 5.  Exercise-induced myokines and their effect on prostate cancer.

Authors:  Jin-Soo Kim; Daniel A Galvão; Robert U Newton; Elin Gray; Dennis R Taaffe
Journal:  Nat Rev Urol       Date:  2021-06-22       Impact factor: 14.432
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.